Correlation Between Myovant Sciences and Design Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Myovant Sciences and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Myovant Sciences and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Myovant Sciences and Design Therapeutics, you can compare the effects of market volatilities on Myovant Sciences and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Myovant Sciences with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Myovant Sciences and Design Therapeutics.

Diversification Opportunities for Myovant Sciences and Design Therapeutics

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Myovant and Design is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Myovant Sciences and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and Myovant Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Myovant Sciences are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of Myovant Sciences i.e., Myovant Sciences and Design Therapeutics go up and down completely randomly.

Pair Corralation between Myovant Sciences and Design Therapeutics

Given the investment horizon of 90 days Myovant Sciences is expected to generate 0.8 times more return on investment than Design Therapeutics. However, Myovant Sciences is 1.25 times less risky than Design Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Design Therapeutics is currently generating about -0.01 per unit of risk. If you would invest  989.00  in Myovant Sciences on January 20, 2024 and sell it today you would earn a total of  1,709  from holding Myovant Sciences or generate 172.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy43.64%
ValuesDaily Returns

Myovant Sciences  vs.  Design Therapeutics

 Performance 
       Timeline  
Myovant Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Myovant Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Myovant Sciences is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Design Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Design Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady technical and fundamental indicators, Design Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Myovant Sciences and Design Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Myovant Sciences and Design Therapeutics

The main advantage of trading using opposite Myovant Sciences and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Myovant Sciences position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.
The idea behind Myovant Sciences and Design Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Money Managers
Screen money managers from public funds and ETFs managed around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance